StonvexLoading…
StonvexStonvexStonvexCore line items from DVLT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.42M | $39.09M | $5.27M | $2.36M |
Operating Income | $-30.95M | $-32.48M | $-36.65M | $-21.89M |
Net Income | $-53.13M | $-78.99M | $-79.66M | $-37.12M |
EPS (Diluted) | $-0.09 | $-0.52 | $-1.05 | $-0.77 |
Total Assets | $250.11M | $274.70M | $138.66M | $120.69M |
Total Liabilities | $30.09M | $36.73M | $39.15M | $46.62M |
Cash & Equivalents | $2.21M | $2.00M | $1.68M | $662.00K |
Free Cash Flow OCF − CapEx | $-8.99M | $-23.99M | $-23.26M | $-12.88M |
Shares Outstanding | 617.81M | 573.44M | 217.20M | 86.66M |